Impact of pear1 gene polymorphisms on clinical outcomes of chinese acute coronary syndrome patients
- In: D25 What’s new in industry & science? Part 2 on Thursday, 6 September 2018, 10:50 -11:00
- At: Glasgow (Scotland) (2018)
- Type: Presentation
- By: QIN, Sibei (PEKING UNIVERSITY HEALTH SCIENCE CENTER, China)
- Co-author(s): Si-Bei Qin: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
Xiao-Yan NIE: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
Yu FU: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
Jun-Lei LI: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
Guang-Kai LIANG: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
Lu-Wen SHI: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
Hong SHAO: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
Jian LIU: Department of Cardiology, Peking University People’s Hospital, Beijing, China - Abstract:
Background
Genetic polymorphism might be an explanation to the individual variation in dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. Platelet Endothelial Aggregation Receptor-1 (PEAR1) is a platelet transmembrane protein which plays a crucial role in platelet aggregation. Previous studies implicate polymorphism of PEAR1 is
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023